Log in to search using one of your social media accounts:

 

Varian to spin off Imaging Components x-ray unit
Radiation therapy firm Varian Medical Systems has announced that it is spinning...Read more on AuntMinnie.comRelated Reading: Varian adds linear accelerators in Texas Varian debuts new radiological protection design software Varian posts flat revenues for Q2 Varian completes Calif. installation Varian supports lung cancer trial (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 23, 2016 Category: Radiology Source Type: news

Duke cancer care in Wake County
Treatment Terms Cancer Anal cancer Bile duct cancer Bladder cancer Breast cancer Colon cancer Esophageal cancer Gallbladder cancer Kidney cancer Liver cancer Lung cancer Oral cancer Ovarian cancer Pancreatic cancer Prostate cancer Rectal cancer Skin cancers Skull base tumor Spine cancer Stomach cancer Testicular cancer Throat and voice box cancer Thyroid cancer Tracheal cancer Uterine cancer Vaginal cancer and vulvar cancer Additional SEO Keywords cancer imaging and treatment in Cary...
Source: dukehealth.org: Duke Health News - May 20, 2016 Category: Consumer Health News Authors: dg62 Source Type: news

Elekta Surpasses One Million Patients Treated with Leksell Gamma Knife
Most clinically proven and comprehensively studied stereotactic radiosurgery and radiation therapy platform with more than 2,800 peer-reviewed journal articles published to date STOCKHOLM, May 19, 2016 -- (Healthcare Sales & Marketing Network) -- At th... Devices, Oncology, NeurosurgeryElekta, Leksell, Gamma Knife, radiosurgery, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 19, 2016 Category: Pharmaceuticals Source Type: news

Conventional Radiation Therapy May Not Protect Healthy Brain Cells
A new study shows that repeated radiation therapy used to target tumors in the brain may not be as safe to healthy brain cells as previously assumed. The findings, which appear in the International Journal of Radiation Oncology, Biology, Physics, show that the treatment also kills important support cells in the brain and may cause as much, if not more damage, than single dose radiation therapy. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - May 18, 2016 Category: Universities & Medical Training Source Type: news

Children with brain tumors undergoing radiation therapy helped by play-based preparation
Support interventions by child life specialists decrease sedation use and costs associated with cranial radiation therapy, new research shows. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 18, 2016 Category: Science Source Type: news

Conventional radiation therapy may not protect healthy brain cells
Repeated radiation therapy used to target tumors in the brain may not be as safe to healthy brain cells as previously assumed. The findings of a new study show that the treatment also kills important support cells in the brain and may cause as much, if not more damage, than single dose radiation therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 18, 2016 Category: Science Source Type: news

Conventional radiation therapy may not protect healthy brain cells
(University of Rochester Medical Center) A new study shows that repeated radiation therapy used to target tumors in the brain may not be as safe to healthy brain cells as previously assumed. The findings, which appear in the International Journal of Radiation Oncology, Biology, Physics, show that the treatment also kills important support cells in the brain and may cause as much, if not more damage, than single dose radiation therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 18, 2016 Category: Global & Universal Source Type: news

When Cancer Glows
By Drs. David Niesel and Norbert Herzog, Medical Discovery News When surgeons remove a cancerous tumor, their goal is to remove all of it. But determining which cells are cancerous and which are healthy is tough. A pathologist's job is to quickly examine the excised tissue to determine whether all of the tumor has been removed. Sometimes, despite a medical team's best efforts, later MRI and CT scans reveal that cancer cells have been left along the margins. As a solution, scientists are looking for ways to light up cancer cells so that surgeons can see them more easily during an operation. Scientists at the Massachusetts...
Source: Science - The Huffington Post - May 17, 2016 Category: Science Source Type: news

Longing for Carefree Days: Grateful After Breast Cancer
I was diagnosed with breast cancer in June 2015. I share my learning that jolted me back on track to a new life. This is my fifth posting. The sun was shining non-stop during July and August in Stockholm. Facebook was filled with pictures of the perfect holiday. As the initial feeling of shock was calming down, I started to long for carefree days. Carefree days. What a wonderful taste these two words have. Carefreeness is a state of mind, but I longed to be carefree on the savanna in Kenya. I have travelled to many wonderful places in the world, but nothing beats waking up in the Masai Mara as the sun rises, putting on ...
Source: Healthy Living - The Huffington Post - May 11, 2016 Category: Consumer Health News Source Type: news

Radiation causing Osteoradionecrosis and peri-implantitis:
Can implants placed years before radiation therapy develop peri-implantitis and osteoradionecrosis? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - May 9, 2016 Category: Dentistry Authors: osseonews Tags: Implant News Source Type: news

Radiation causing Osteoradionecrosis and peri-implantitis: significant concern?
Can implants placed years before radiation therapy develop peri-implantitis and osteoradionecrosis? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - May 9, 2016 Category: Dentistry Authors: osseonews Tags: Implant News Source Type: news

Varian debuts new radiological protection design software
Radiation therapy firm Varian Medical Systems has released new computer-aided...Read more on AuntMinnie.comRelated Reading: Varian posts flat revenues for Q2 Varian completes Calif. installation Varian supports lung cancer trial Varian opens office in Algeria Varian launches new Beacon transponder (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 9, 2016 Category: Radiology Source Type: news

New bone marrow-on-a-chip can model radiation therapy damage and assess preventive measures
(Mary Ann Liebert, Inc./Genetic Engineering News) Engineered bone marrow grown in a novel microfluidic chip device responds to damaging radiation exposure followed by treatment with compounds that aid in blood cell recovery in a way that mimics living bone marrow. This new bone marrow-on-a-chip microdevice holds promise for testing and developing improved radiation countermeasures, as described in Tissue Engineering, Part C, Methods. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 4, 2016 Category: Global & Universal Source Type: news

Accuray, MedPhoton ink deal to integrate ImagingRing into CyberKnife
Accuray (NSDQ:ARAY) said today it inked a collaborative deal with MedPhoto GmbH to integrate its ImagingRing volumetric image guidance system into Accuray’s CyberKnife radiosurgery system. The ImagingRing system provides a range of imaging capabilities including large field-of-view cone beam CT, the Sunnyvale, Calif.-based company said. Through the agreement, Accuray will maintain exclusive development, sales and distribution rights to the ImagingRing for use in adaptive radiation therapy, SBRT and robotic radiosurgery. “This collaboration with medPhoton enables us to partner with a company which, like our...
Source: Mass Device - May 2, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Imaging Accuray Inc. Source Type: news

Radiotherapy for lung cancer linked to non-cancer deaths, study says
Stephen FellerTURIN, Italy, May 2 (UPI) -- Patients treated for non-small cell lung cancer with radiation therapy have a higher risk of death from non-cancer causes, according to researchers. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 2, 2016 Category: Consumer Health News Source Type: news

Radiotherapy more effective than chemotherapy for early stage II testicular cancer
A large study of testicular cancer patients has shown that radiation therapy is a better treatment than chemotherapy for patients with stage IIa disease (where one or more regional lymph nodes contain cancer cells but they are less than 2 cm in diameter). These findings are important because, until now, there has been little evidence about which treatment for testicular seminoma is more effective. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 2, 2016 Category: Science Source Type: news

Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 2, 2016 Category: Science Source Type: news

Radiation and immunotherapy combination can destroy both primary and secondary tumors
The addition of an immune system-strengthening compound to radiation therapy can extend the radiation therapy-induced immune response against the tumor sites and that this response even has an effect on tumors outside the radiation field. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 2, 2016 Category: Science Source Type: news

Radiotherapy more effective than chemotherapy for early stage II testicular cancer
(European Society for Radiotherapy and Oncology (ESTRO)) A large study of testicular cancer patients has shown that radiation therapy is a better treatment than chemotherapy for patients with stage IIa disease (where one or more regional lymph nodes contain cancer cells but they are less than 2 cm in diameter). These findings, presented at the ESTRO 35 conference and published simultaneously in Clinical Oncology, are important because, until now, there has been little evidence about which treatment for testicular seminoma is more effective. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2016 Category: Global & Universal Source Type: news

Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
(European Society for Radiotherapy and Oncology (ESTRO)) Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer. The findings are presented at the annual meeting of the European Society for Radiotherapy and Oncology - ESTRO35. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2016 Category: Global & Universal Source Type: news

Is breast conserving therapy or mastectomy better for early breast cancer?
Young women with early breast cancer face a difficult choice about whether to opt for a mastectomy or breast conserving therapy (BCT). New research has shown young women, who had early stage breast cancer that had not spread to the lymph nodes and who opted for BCT with radiation therapy, had a 13 percent higher risk of developing a local recurrence of their disease over a 20-year period than women who had a mastectomy and no radiation therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 30, 2016 Category: Science Source Type: news

Radiation and immunotherapy combination can destroy both primary and secondary tumors
(European Society for Radiotherapy and Oncology (ESTRO)) Research to be presented to the ESTRO 35 conference today has shown that the addition of an immune system-strengthening compound to radiation therapy can extend the radiation therapy-induced immune response against the tumor sites and that this response even has an effect on tumors outside the radiation field. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 30, 2016 Category: Cancer & Oncology Source Type: news

Is breast conserving therapy or mastectomy better for early breast cancer?
(European Society for Radiotherapy and Oncology (ESTRO)) Young women with early breast cancer face a difficult choice about whether to opt for a mastectomy or breast conserving therapy (BCT). New research presented at the ESTRO 35 conference has shown young women, who had early stage breast cancer that had not spread to the lymph nodes and who opted for BCT with radiation therapy, had a 13 percent higher risk of developing a local recurrence of their disease over a 20-year period than women who had a mastectomy and no radiation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 29, 2016 Category: Cancer & Oncology Source Type: news

Varian posts flat revenues for Q2
Radiation therapy firm Varian Medical Systems posted flat total revenues in...Read more on AuntMinnie.comRelated Reading: Varian completes Calif. installation Varian supports lung cancer trial Varian opens office in Algeria Varian launches new Beacon transponder Varian preps new products for ECR 2016 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 28, 2016 Category: Radiology Source Type: news

Radiation oncology grant money available
The Radiation Oncology Institute has made available $200,000 in grant money...Read more on AuntMinnie.comRelated Reading: Institute awards radiation therapy grants ROI requests radiation therapy research proposals ASTRO nears funding goal for Radiation Oncology Institute (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 28, 2016 Category: Radiology Source Type: news

No Worries: PSA 'Bounce' With Prostate Cancer Tied to SexNo Worries: PSA 'Bounce' With Prostate Cancer Tied to Sex
A small rise and fall in PSA level commonly occurs after radiation therapy for prostate cancer. These bounces are strongly associated with erectile function status, a new study says. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Metastectomies: Local Approaches to Breast Cancer MetastasesMetastectomies: Local Approaches to Breast Cancer Metastases
In expert panel reported on the increasing the use of radiation therapy and surgery to control low-volume metastatic disease in patients with breast cancer, as part of the 2016 EBCC in Amsterdam. Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 28, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology Article Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 25, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Questions surface about Palmaz Scientific’s fundraising Palmaz Scientific, which filed for Chapter 11 bankruptcy protection last month, is reportedly embroiled in a dispute with Jefferies & Co. over its claim that the...
Source: Mass Device - April 25, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

FDA grants IDE to NovoCure for phase II Optune trial
NovoCure (NSDQ:NVCR) said today that Radiation Therapy Oncology Group Foundation won FDA investigational device exemption to conduct a Phase II pilot test of NovoCure’s Optune in conjunction with bevacizumab to treat bevacizumab-refractory recurrent glioblastoma. The Optune is a mobile device that delivers low-intensity, intermediate frequency, alternating electric fields, referred to as “tumor treating fields” to inhibit cancer cell replication and cause cancer cell death. “This is the 1st consortium study of TTFields, representing a growing interest in TTFields therapy from the scientifi...
Source: Mass Device - April 25, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Oncology NovoCure Source Type: news

Varian supports lung cancer trial
Radiation therapy firm Varian Medical Systems is endorsing a phase III trial...Read more on AuntMinnie.comRelated Reading: Varian opens office in Algeria Varian launches new Beacon transponder Varian preps new products for ECR 2016 Varian posts mixed Q1 results Varian gets Saudi OK for proton therapy system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 21, 2016 Category: Radiology Source Type: news

DITTA endorses refurbishment standards
The Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association...Read more on AuntMinnie.comRelated Reading: JIRA begins 2-year chairmanship of DITTA (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 20, 2016 Category: Radiology Source Type: news

Delay in Radiation Increases Ipsilateral Breast Cancer RiskDelay in Radiation Increases Ipsilateral Breast Cancer Risk
Women eligible for adjuvant radiation therapy increase their risk for ipsilateral breast cancer if they delay getting radiation therapy 8 weeks beyond surgery. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Delaying radiation therapy for women with very early breast cancer ups recurrence
Delaying radiation therapy too long after surgery significantly increases the risk of recurrent tumors in women treated for very early, or what is referred to as 'stage 0,' breast cancer, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 19, 2016 Category: Science Source Type: news

Study: SBRT has 98 percent cure rate for prostate cancer
Stephen FellerDALLAS, April 18 (UPI) -- An alternative method of delivering radiation therapy to prostate cancer patients had a nearly 100 percent cure rate, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 18, 2016 Category: Consumer Health News Source Type: news

98 percent cure rate for prostate cancer using stereotactic body radiation therapy, research shows
A new study -- the first trial to publish five-year results from SBRT treatment for prostate cancer -- found a 98.6 percent cure rate with SBRT, a noninvasive form of radiation treatment that involves high-dose radiation beams entering the body through various angles and intersecting at the desired target. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 18, 2016 Category: Science Source Type: news

Delayed rad therapy puts women with DCIS at risk
Women being treated for ductal carcinoma in situ (DCIS) are at higher risk...Read more on AuntMinnie.comRelated Reading: Socioeconomic factors affect patient care in radiology Racial discrepancies persist in breast cancer diagnoses Choosing Wisely boosts use of short-course breast radiation therapy Accelerated RT with boost works well for breast cancer patients ASTRO publishes guidelines for accelerated whole-breast RT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 18, 2016 Category: Radiology Source Type: news

Varian backs Phase III non-small cell lung cancer trial
Varian Medical (NYSE:VAR) said today it is supporting a Phase III clinical trial set to compare outcomes of radiosurgery against surgical resection for treating early-stage, high-risk operable non-small cell lung cancer. The randomized “Stablemates Trial” will test the hypothesis that 3-year overall survival in high risk operable patients with Stage I NSCLC is equivalent or greater in patients who undergo stereotactic ablative radiotherapy compared to conventional surgery, the company said. “In addition to a potentially longer survival rate, SAbR may benefit some lung cancer patients by off...
Source: Mass Device - April 18, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Oncology Radiosurgery Varian Medical Systems Source Type: news

Delaying radiation therapy for women with very early breast cancer ups recurrence
(Washington University School of Medicine) Delaying radiation therapy too long after surgery significantly increases the risk of recurrent tumors in women treated for very early, or what is referred to as 'stage 0,' breast cancer, according to new research at Washington University School of Medicine in St. Louis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 18, 2016 Category: Cancer & Oncology Source Type: news

How doctors are developing new payment models for their specialties
New regulations under the Medicare Access and CHIP Reauthorization Act (MACRA) are on their way, and physicians will have a choice to participate in the new Merit-based Incentive Payment System or alternative payment models (APM). It’s important that physicians are involved and leading the way now in the design of APMs to ensure they work for both their patients and their practices. Learn how one physician got involved with his specialty society to develop new payment models. Building future payment models As a radiation oncologist in Seattle, Shilpen Patel, MD, saw opportunity in the APM option and began working...
Source: AMA Wire - April 15, 2016 Category: Journals (General) Authors: Amy Farouk Source Type: news

Radiation may help after surgery for 'soft-tissue' cancers
HealthDay News Older patients with a type of cancer called soft-tissue sarcomas may benefit more from radiation therapy after surgery than younger patients do.. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 14, 2016 Category: Consumer Health News Source Type: news

RefleXion secures more funding
Radiation therapy equipment developer RefleXion Medical has completed a $46...Read more on AuntMinnie.comRelated Reading: Mirada inks deal with RefleXion CliQr gains radiation therapy firm as client (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 14, 2016 Category: Radiology Source Type: news

Radiation May Help After Surgery for 'Soft-Tissue' Cancers
Biggest benefit was seen in people over 65, research suggests Source: HealthDay Related MedlinePlus Pages: Radiation Therapy, Soft Tissue Sarcoma, Surgery (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 14, 2016 Category: Consumer Health News Source Type: news

Radiation May Help After Surgery for 'Soft-Tissue' Cancers
THURSDAY, April 14, 2016 -- Older patients with a type of cancer called soft-tissue sarcomas may benefit more from radiation therapy after surgery than younger patients do, a new study suggests. The results might change the way older patients are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 14, 2016 Category: Journals (General) Source Type: news

IsoRay spikes GliaSite radiation therapy device
IsoRay (NYSE:ISR) said yesterday that it’s spiking its GliaSite radiation therapy system for treating brain cancers, after achieving only modest sales since the FDA cleared the device in 2011. Richland, Wash.-based IsoRay said it’s cancelling its deals with Dr. Reddy’s Laboratories (NYSE:RDY), Hologic (NSDQ:HOLX) and Karlheinz Goehl-Medizintechnik Goehl concerning GliaSite. “The GliaSite product has resulted in only marginal sales, but it was the first delivery system available to the company to deliver brachytherapy radiation in the treatment of brain cancer. Management believes...
Source: Mass Device - April 13, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Oncology Radiosurgery IsoRay Source Type: news

The holistic health approach is the best way to fight cancer fatigue
(NaturalNews) Many people are unaware that fatigue is the most common side effect of traditional cancer treatments. In fact, there is research suggesting that most people receiving traditional cancer treatment, including chemotherapy and radiation therapy, are beset with fatigue,... (Source: NaturalNews.com)
Source: NaturalNews.com - April 12, 2016 Category: Consumer Health News Source Type: news

Red Journal's May 2016 edition features special focus on particle therapy
(American Society for Radiation Oncology) The International Journal of Radiation Oncology Biology Physics' (Red Journal) May edition is a special issue focused entirely on particle therapy. It will feature papers showcasing the 'best available evidence' on the value of particle therapy, as well as editorials and commentaries about its place in the radiation therapy (RT) arsenal. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 12, 2016 Category: Cancer & Oncology Source Type: news

Moffitt researchers discover liver metastases have different radiation sensitivities
(H. Lee Moffitt Cancer Center & Research Institute) Radiation is a commonly used therapeutic option to treat liver metastases, with the majority of tumors maintained under control after one year. However, some patients do not respond as well to radiation treatment, and the factors that predict patient outcomes are unclear. Moffitt Cancer Center researchers report that liver metastases have different sensitivities to radiation therapy based on the location of the primary tumor. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 12, 2016 Category: Cancer & Oncology Source Type: news

Radiation improves survival in older patients with soft tissue sarcomas
Radiation therapy following surgery benefits older patients more than their younger counterparts, researchers report, a surprising finding that could change the way some patients are treated for soft tissue sarcomas (STS). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 11, 2016 Category: Science Source Type: news

Common prostate cancer treatments suppress immune response, may promote relapse
Prostate cancer patients and their doctors may want to think twice about the best timing for chemotherapy or radiation therapy in conjunction with a common nonsurgical treatment, based on international research findings. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 8, 2016 Category: Science Source Type: news

Radiation therapy chemotherapy combination improves survival in adults with low-grade brain cancer
Patients with a low-grade type of brain tumor called glioma who received radiation therapy plus a chemotherapy regimen, including procarbazine, lomustine and vincristine (PCV), experienced a longer progression-free survival and overall survival than patients who received radiation therapy alone, according to the results of the clinical trial. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 7, 2016 Category: Science Source Type: news